CareTrust REIT Details Over $637M in Acquisitions and Active ATM Program Utilization

summarizeSummary

CareTrust REIT reported strong Q1 2026 financial results and detailed over $637 million in recent acquisitions and investments, alongside active utilization of its At-The-Market equity offering program, which generated $129.5 million in proceeds and has $363.6 million in unsettled forward contracts.

check_boxKey Events

• Significant Capital Deployment in Acquisitions

  The company detailed over $637 million in subsequent acquisitions and investments, including senior housing communities and skilled nursing facilities in the U.S. and U.K., demonstrating aggressive expansion.

• Active At-The-Market (ATM) Program Utilization

  CareTrust REIT reported selling 3.5 million shares for $129.5 million in gross proceeds during Q1 2026 and has 9.5 million shares, representing $363.6 million, remaining unsettled under forward contracts from its $1.0 billion ATM program.

• Strong Q1 Financial Performance

  Net income attributable to CareTrust REIT, Inc. increased to $80.2 million for Q1 2026, with basic and diluted EPS at $0.36. Rental income grew by 59% compared to the prior year period.

• CEO's 10b5-1 Plan Terminated

  President and CEO David Sedgwick terminated a Rule 10b5-1 trading arrangement to sell up to 144,492 shares, removing a potential selling overhang.

auto_awesomeAnalysis

This 10-Q provides comprehensive details on CareTrust REIT's robust growth strategy and its financing. The company reported strong Q1 2026 financial results, with significant increases in rental income and net income. Crucially, the filing details over $637 million in subsequent acquisitions and investments, demonstrating aggressive expansion in the healthcare real estate sector. This substantial capital deployment is being funded in part by the active utilization of its At-The-Market equity program, which has already generated $129.5 million in proceeds and has $363.6 million in unsettled forward contracts, indicating a proactive approach to capital management. The termination of the CEO's 10b5-1 selling plan also removes a minor potential overhang. Investors should view this filing as confirmation of the company's strong operational performance and its continued execution on growth initiatives, supported by effective financing strategies.